MedMira Reports Second Quarter Results FY2024

Stock Information for MedMira Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About MedMira Inc.

MedMira Reports Second Quarter Results FY2025
MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense
MedMira Reports Second Quarter Results FY2025
MedMira Announces Partnership with MediGroup Physician Services in the United States
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications
MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use
MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.